Medication info

Curamus Duo Dry Syrup [Amoxicillin-Potassium Clavulanate (7:1)]

Prescription medicationSyrupOral
Ingredient · strength
Amoxicillin Hydrate›36.3143g / 100gDilute Potassium Clavulanate›5.1878g / 100g
Manufacturer / importer
Jeongwoo Pharmaceutical Co., Ltd.
Appearance
A whitish powder with a peculiar smell, a syrup that is dissolved before use
Packaging
50mL/bottle, 500mL/bottle
Approval status
Active

MFDS item code 201900126 · Notified 2019.01.11

Summary

Main use
Treatment of respiratory and otolaryngologic infections, genitourinary infections, and skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
To minimize potential gastrointestinal intolerance, administer at the beginning of a meal. Absorption of amoxicillin-clavulanic acid is optimized when administered at the beginning of a meal. <Preparation of this medicine> Add water to about 2/3 of the marked line, mix well, then add water up to the line and shake thoroughly before use.
Child dose
For mild to moderate infections, including upper respiratory tract infections such as recurrent tonsillitis, lower respiratory tract infections, urinary tract infections, and skin and soft tissue infections, the usual dosage is 25 mg/3.6 mg per kg of body weight per day as amoxicillin/potassium clavulanate, divided into 2 doses. For severe infections, including upper respiratory tract infections such as otitis media and sinusitis, lower respiratory tract infections such as bronchopneumonia, and urinary tract infections, the usual dosage is 45 mg/6.4 mg per kg of body weight per day as amoxicillin/potassium clavulanate, divided into 2 doses. The 7 : 1 syrup is not suitable for children under 2 months of age. The 7 : 1 syrup is not suitable for pediatric patients with renal impairment.

Ingredients

Manufacturer
Jeongwoo Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of respiratory and otolaryngologic infections, genitourinary infections, and skin, bone, and dental infections

  • Acute bronchitis
  • chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
View approved original text

This medication is effective against various bacterial infections. It treats respiratory infections such as acute and chronic bronchitis and pneumonia, and is also used for sinusitis, tonsillitis, and otitis media. It helps in the treatment of urinary tract infections such as cystitis, urethritis, and pyelonephritis. Additionally, it improves pelvic infections and sexually transmitted diseases like gonorrhea, as well as abscesses, soft tissue infections, and wound infections. It is used for the treatment of osteomyelitis and dental infections, addressing a wide range of bacterial infections.

How to take

Adult dose

To minimize potential gastrointestinal intolerance, administer at the beginning of a meal. Absorption of amoxicillin-clavulanic acid is optimized when administered at the beginning of a meal. <Preparation of this medicine> Add water to about 2/3 of the marked line, mix well, then add water up to the line and shake thoroughly before use.

Child dose

For mild to moderate infections, including upper respiratory tract infections such as recurrent tonsillitis, lower respiratory tract infections, urinary tract infections, and skin and soft tissue infections, the usual dosage is 25 mg/3.6 mg per kg of body weight per day as amoxicillin/potassium clavulanate, divided into 2 doses. For severe infections, including upper respiratory tract infections such as otitis media and sinusitis, lower respiratory tract infections such as bronchopneumonia, and urinary tract infections, the usual dosage is 45 mg/6.4 mg per kg of body weight per day as amoxicillin/potassium clavulanate, divided into 2 doses. The 7 : 1 syrup is not suitable for children under 2 months of age. The 7 : 1 syrup is not suitable for pediatric patients with renal impairment.

Precautions

This medicine contains the artificial sweetener aspartame, so it should not be used by patients with phenylketonuria. The intake of aspartame should be limited to below the WHO recommended levels, with a maximum dose of 2.4 grams per day for the average adult. It should not be administered to patients with allergic reactions to this medication or beta-lactam antibiotics, those with infectious mononucleosis or lymphocytic leukemia, patients with liver impairment or a history of jaundice, or those with lactose intolerance or certain genetic digestive disorders. Caution is advised in patients with impaired liver function or moderate to severe kidney impairment, those with allergic constitutions, patients for whom oral intake is difficult, the elderly, patients in poor general condition, and those with gastrointestinal diseases due to vomiting or diarrhea. During treatment, gastrointestinal symptoms such as diarrhea, dyspepsia, vomiting, and abdominal pain may occur, so attention is needed, and immediate medical attention should be sought if any allergic reactions such as liver dysfunction, skin rashes, or respiratory difficulties appear. It is recommended to administer this medication only for the necessary minimum duration to prevent the emergence of resistant bacteria, and patients with hypersensitivity to penicillin drugs should be particularly cautious. Close observation of the patient should be conducted after administration due to the risk of acute allergic reactions. Severe gastrointestinal diseases such as pseudomembranous colitis may occur, so if there is severe diarrhea or abdominal cramping, treatment should be discontinued immediately and the patient should be taken to the hospital. During prolonged administration, regular checks of liver function, kidney function, and blood status should be conducted, and a thorough history of allergies should be confirmed before administering the medication. This medication should be stored in the refrigerator and should be finished within 7 days after preparation. Additionally, since this medication may interact with other drugs, it is essential to inform the healthcare provider of any other medications being taken. Women who are pregnant or breastfeeding should use this medication cautiously after consulting with a doctor, and it is particularly advisable to avoid use during the first three months of pregnancy. It is preferable not to use this medication in children, especially newborns or premature infants under 2 months of age, as safety has not been established. Elderly patients may experience adverse reactions more easily due to decreased bodily functions, so the dosage and intervals should be adjusted, and careful monitoring is necessary. In case of overdose, gastrointestinal symptoms, kidney dysfunction, or allergic reactions may occur, so treatment should be stopped immediately and appropriate medical attention should be sought.

Side effects

  • Diarrhea
  • pseudomembranous colitis
  • dyspepsia
  • stomatitis
  • gastritis
  • glossitis
  • melena
  • nausea
  • vomiting
  • anorexia
Show 80 more
  • abdominal pain
  • abdominal bloating
  • constipation
  • colonic pain
  • hyperacidity
  • soft stools
  • dry mouth
  • acute pancreatitis
  • candidiasis
  • antibiotic-induced colitis
  • hematochezia
  • itching
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • vesicular exfoliative dermatitis
  • acute generalized pustular psoriasis
  • eosinophilia
  • angioedema
  • anaphylaxis
  • serum sickness syndrome
  • hypersensitivity vasculitis
  • bronchospasm
  • dyspnea
  • laryngeal edema
  • anaphylactic shock
  • leukopenia
  • thrombocytopenia
  • hemolytic anemia
  • anemia
  • thrombocytopenic purpura
  • eosinophilia
  • leukemia
  • agranulocytosis
  • lymphopenia
  • thrombocytosis
  • bone marrow suppression
  • prolonged bleeding time
  • extended prothrombin time
  • mucosal candidiasis
  • vulvar pruritus
  • vulvar burning
  • increased discharge
  • restlessness
  • anxiety
  • behavioral change
  • confusion
  • drowsiness
  • insomnia
  • hyperactivity
  • dizziness
  • headache
  • convulsions
  • anti-spasmodic
  • fever
  • altered consciousness
  • aseptic meningitis
  • acute renal failure
  • interstitial nephritis
  • hematuria
  • crystalluria
  • symptoms of vitamin K deficiency
  • hypoprothrombinemia
  • tendency to bleed
  • symptoms of vitamin B deficiency
  • dysgeusia
  • lethargy
  • dermatitis
  • oral edema
  • stomach pain
  • fluid and electrolyte imbalance
  • rash
  • hyperactivity
  • drowsiness
  • renal failure
  • interstitial seizures
  • hypersensitivity shock
  • skin reactions
  • bleeding
  • pancytopenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, in a cool place between 1 and 25 degrees Celsius. Storing it this way helps maintain the drug's efficacy for a longer period.

Appearance and packaging

Appearance

A whitish powder with a peculiar smell, a syrup that is dissolved before use

Package unit

50mL/bottle, 500mL/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.